Advertisement

 

 

This patient is not breathing properly: is this COPD, heart failure, or neither?

This patient is not breathing properly: is this COPD, heart failure, or neither?
Author Information (click to view)

Pellicori P, Salekin D, Pan D, Clark AL,


Pellicori P, Salekin D, Pan D, Clark AL, (click to view)

Pellicori P, Salekin D, Pan D, Clark AL,

Advertisement

Expert review of cardiovascular therapy 2017 04 11() doi 10.1080/14779072.2017.1317592
Abstract
INTRODUCTION
Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are two common, heterogeneous, long-term illnesses which cause significant morbidity and mortality. Although they both present with breathlessness, they are treated differently. Treatment of COPD focuses mainly on relieving short-term breathlessness, whilst treatment of HF has focused on long term morbidity and mortality. Areas covered: In this review, we aim to highlight the diagnostic challenges in distinguishing COPD from HF. We also explore the implications of their overlap, and the use of biomarkers and treatments for HF in patients with COPD to improve long-term outcomes. Expert commentary: Cardiovascular morbidity and mortality amongst patients with COPD is substantial. Approaches which identify patients with COPD at highest cardiovascular risk may therefore be helpful. A trial targeting those patients with COPD and raised natriuretic peptide levels might be the way to test whether cardiovascular medication has anything to offer the respiratory patient.

Submit a Comment

Your email address will not be published. Required fields are marked *

19 + 14 =

[ HIDE/SHOW ]